FC Stock News
Monday, November 06, 2006
Abbott To Buy Kos
Abbott Laboratories (ABT) agreed to acquire the cholesterol drugmaker Kos Pharmaceuticals Inc. (KOSP) for $3.7 billion. Shares of Kos leaped $26.97 to close at $77.06 while Abbott stock eased 17 cents to close at $47.47.
posted by FC Market News at
10:52 AM
0 Comments:
Post a Comment
<< Home
About Me
Name:
FC Market News
View my complete profile
Previous Posts
Four Seasons Receives $3.7 Billion Bid
Navteq To Buy Traffic.com
Swift Receives Buyout Offer
CA Lowers Outlook
Electronic Arts Surprises
Syntax-Brillion Reverses Losses
Oracle Buys Stellent
Earnings Slip For Red Robin
Whole Foods Warns Of Slowing Sales Growth
SRA's Forecast Disappoints
0 Comments:
Post a Comment
<< Home